Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1
摘要:
The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.
信息查询
0/0